Up-regulated LncRNA-ATB Regulates the Growth and Metastasis of Cholangiocarcinoma Via MiR-200c Signals

Overview

Journal Onco Targets Ther

Publisher Dove Medical Press

Specialty Oncology

Date 2019 Oct 2

PMID 31571907

Citations 10

Authors

Hai Lin

Lili Yang

Feng Tian

Shuang Nie

Hailang Zhou

Jun Liu

Weichang Chen

Affiliations

Soon will be listed here.

Abstract

Background And Objective: Cholangiocarcinoma (CCA) is a highly aggressive neoplasm featured with regional invasiveness and distant metastasis, which often present a phenotype of epithelial-mesenchymal transition (EMT). Long non-coding RNAs (LncRNAs) are dysregulated during carcinogenesis, and up-regulated LncRNA-activated by TGF-β (Lnc-ATB) supports tumor growth and metastasis via tumor suppressor microRNA 200 (miR-200). However, the role of Lnc-ATB in CCA is unclear.

Methods: CCA tissues and non-cancer tissues (n=30) were used to determine the Lnc-ATB and miR-200a/b/c levels. The functions and mechanisms of Lnc-ATB/miR-200 pathway were determined by knockdown of Lnc-ATB via siRNAs in vitro and in vivo.

Results: CCA tissues have increased Lnc-ATB and reduced miR-200a/b/c levels, but the down-regulated miR-200c was most prominent. Up-regulated Lnc-ATB significant negatively correlated with miR-200c and predicted advanced TNM stage and more lymph node metastasis of CCA patients. Knockdown of Lnc-ATB in two CCA cell lines HuCCT1 and RBE increased miR-200c levels. The luciferase reporter assay further confirmed the direct binding site of miR-200c in Lnc-ATB. Inhibition of Lnc-ATB significantly impaired cell vitality and induced apoptosis and G0/G1 arrest, which, however, was rescued by miR-200c inhibitor. The ability of migration of CCA cells was also up-regulated by Lnc-ATB but was suppressed by miR-200c. Mechanistically, the cell cycle-related CCND1/CDK2, apoptosis-related BCL-2/caspase-3 and EMT-related E-cadherin/ZEB1/2 were regulated by Lnc-ATB via miR-200c. Knockdown of Lnc-ATB in vivo up-regulated miR-200c signals to inhibit tumor growth with decreased PCNA expression in tumor tissues, which was restored by miR-200c inhibition.

Conclusion: Overexpressed Lnc-ATB functioned as an oncogene for CCA growth and metastasis via miR-200 signals.

Citing Articles

A Critical Review on microRNAs as Prognostic Biomarkers in Laryngeal Carcinoma.

Komitova K, Dimitrov L, Stancheva G, Kyurkchiyan S, Petkova V, Dimitrov S Int J Mol Sci. 2025; 25(24.

PMID: 39769234 PMC: 11676902. DOI: 10.3390/ijms252413468.

Unlocking melanoma Suppression: Insights from Plasma-Induced potent miRNAs through PI3K-AKT-ZEB1 axis.

Bhartiya P, Jaiswal A, Negi M, Kaushik N, Choi E, Kaushik N J Adv Res. 2024; 68:147-161.

PMID: 38447612 PMC: 11785563. DOI: 10.1016/j.jare.2024.02.022.

TGFβ-induced long non-coding RNA LINC00313 activates Wnt signaling and promotes cholangiocarcinoma.

Papoutsoglou P, Pineau R, Leroux R, Louis C, LHaridon A, Foretek D EMBO Rep. 2024; 25(3):1022-1054.

PMID: 38332153 PMC: 10933437. DOI: 10.1038/s44319-024-00075-z.

Xiaotan Sanjie Decoction Inhibits Gastric Cancer Cell Proliferation, Migration, and Invasion through lncRNA-ATB and miR-200A.

Zhou Z, Chen J, Li M, Cao L, Chen M, Zhang Q Biomed Res Int. 2022; 2022:7029182.

PMID: 36060143 PMC: 9436559. DOI: 10.1155/2022/7029182.

Potential of the miR-200 Family as a Target for Developing Anti-Cancer Therapeutics.

Jo H, Shim K, Jeoung D Int J Mol Sci. 2022; 23(11).

PMID: 35682560 PMC: 9180509. DOI: 10.3390/ijms23115881.

References

Vaquero J, Guedj N, Claperon A, Nguyen Ho-Bouldoires T, Paradis V, Fouassier L . Epithelial-mesenchymal transition in cholangiocarcinoma: From clinical evidence to regulatory networks. J Hepatol. 2016; 66(2):424-441. DOI: 10.1016/j.jhep.2016.09.010. View

Li Z, Wu X, Gu L, Shen Q, Luo W, Deng C . Long non-coding RNA ATB promotes malignancy of esophageal squamous cell carcinoma by regulating miR-200b/Kindlin-2 axis. Cell Death Dis. 2017; 8(6):e2888. PMC: 5520904. DOI: 10.1038/cddis.2017.245. View

Li Z, Li J, Ji D, Leng K, Xu Y, Huang L . Overexpressed long noncoding RNA Sox2ot predicts poor prognosis for cholangiocarcinoma and promotes cell proliferation and invasion. Gene. 2017; 645:131-136. DOI: 10.1016/j.gene.2017.12.017. View

Cao Y, Luo X, Ding X, Cui S, Guo C . LncRNA ATB promotes proliferation and metastasis in A549 cells by down-regulation of microRNA-494. J Cell Biochem. 2018; 119(8):6935-6942. DOI: 10.1002/jcb.26894. View

Gong X, Huang M . Long non-coding RNA MEG3 promotes the proliferation of glioma cells through targeting Wnt/β-catenin signal pathway. Cancer Gene Ther. 2017; 24(9):381-385. DOI: 10.1038/cgt.2017.32. View

Mao X, Chen D, Wu J, Li J, Zhou H, Wu Y . Differential expression of fascin, E-cadherin and vimentin: Proteins associated with survival of cholangiocarcinoma patients. Am J Med Sci. 2012; 346(4):261-8. DOI: 10.1097/MAJ.0b013e3182707108. View

Gatto M, Bragazzi M, Semeraro R, Napoli C, Gentile R, Torrice A . Cholangiocarcinoma: update and future perspectives. Dig Liver Dis. 2010; 42(4):253-60. DOI: 10.1016/j.dld.2009.12.008. View

Hammill C, Wong L . Intrahepatic cholangiocarcinoma: a malignancy of increasing importance. J Am Coll Surg. 2008; 207(4):594-603. DOI: 10.1016/j.jamcollsurg.2008.04.031. View

Yuan J, Yang F, Wang F, Ma J, Guo Y, Tao Q . A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell. 2014; 25(5):666-81. DOI: 10.1016/j.ccr.2014.03.010. View

10.

Shi X, Zhang H, Wang M, Xu X, Zhao Y, He R . LncRNA AFAP1-AS1 promotes growth and metastasis of cholangiocarcinoma cells. Oncotarget. 2017; 8(35):58394-58404. PMC: 5601661. DOI: 10.18632/oncotarget.16880. View

11.

Tang Y, Cheung B, Atmadibrata B, Marshall G, Dinger M, Liu P . The regulatory role of long noncoding RNAs in cancer. Cancer Lett. 2017; 391:12-19. DOI: 10.1016/j.canlet.2017.01.010. View

12.

Lim J, Park C . Pathology of cholangiocarcinoma. Abdom Imaging. 2004; 29(5):540-7. DOI: 10.1007/s00261-004-0187-2. View

13.

Khan S, Davidson B, Goldin R, Heaton N, Karani J, Pereira S . Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut. 2012; 61(12):1657-69. DOI: 10.1136/gutjnl-2011-301748. View

14.

Dong Z, Zhang A, Liu S, Lu F, Guo Y, Zhang G . Aberrant Methylation-Mediated Silencing of lncRNA MEG3 Functions as a ceRNA in Esophageal Cancer. Mol Cancer Res. 2017; 15(7):800-810. DOI: 10.1158/1541-7786.MCR-16-0385. View

15.

Patel T . Cholangiocarcinoma. Nat Clin Pract Gastroenterol Hepatol. 2006; 3(1):33-42. DOI: 10.1038/ncpgasthep0389. View

16.

Xu Y, Jiang X, Cui Y . Upregulated long noncoding RNA PANDAR predicts an unfavorable prognosis and promotes tumorigenesis in cholangiocarcinoma. Onco Targets Ther. 2017; 10:2873-2883. PMC: 5476724. DOI: 10.2147/OTT.S137044. View

17.

Lei K, Liang X, Gao Y, Xu B, Xu Y, Li Y . Lnc-ATB contributes to gastric cancer growth through a MiR-141-3p/TGFβ2 feedback loop. Biochem Biophys Res Commun. 2017; 484(3):514-521. DOI: 10.1016/j.bbrc.2017.01.094. View

18.

Esnaola N, Meyer J, Karachristos A, Maranki J, Camp E, Denlinger C . Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma. Cancer. 2016; 122(9):1349-69. DOI: 10.1002/cncr.29692. View

19.

Tan X, Huang Z, Li X . Long Non-Coding RNA MALAT1 Interacts With miR-204 to Modulate Human Hilar Cholangiocarcinoma Proliferation, Migration, and Invasion by Targeting CXCR4. J Cell Biochem. 2017; 118(11):3643-3653. DOI: 10.1002/jcb.25862. View

20.

Wang W, Ye H, Wei P, Han B, He B, Chen Z . LncRNAs H19 and HULC, activated by oxidative stress, promote cell migration and invasion in cholangiocarcinoma through a ceRNA manner. J Hematol Oncol. 2016; 9(1):117. PMC: 5093965. DOI: 10.1186/s13045-016-0348-0. View